BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37307626)

  • 21. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways.
    Andtbacka RH; Babiera G; Singletary SE; Hunt KK; Meric-Bernstam F; Feig BW; Ames FC; Ross MI; Dejesus Y; Kuerer HM
    Ann Surg; 2006 Jan; 243(1):96-101. PubMed ID: 16371742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing and risks of chemoprophylaxis after spinal surgery: a single-center experience with 6869 consecutive patients.
    Dhillon ES; Khanna R; Cloney M; Roberts H; Cybulski GR; Koski TR; Smith ZA; Dahdaleh NS
    J Neurosurg Spine; 2017 Dec; 27(6):681-693. PubMed ID: 28885127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis.
    Xiang L; Jin S; Yu Y; Wang D; Chen H
    BMC Cancer; 2023 Oct; 23(1):933. PubMed ID: 37789268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy.
    Laws A; Anderson K; Hu J; McLean K; Novak L; Dominici LS; Nakhlis F; Carty M; Caterson S; Chun Y; Duggan M; Barry W; Connell N; Golshan M; King TA
    Ann Surg Oncol; 2018 Nov; 25(12):3548-3555. PubMed ID: 30128903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of inpatient versus post-discharge venous thromboembolic events after spinal surgery: A single institution series of 6869 consecutive patients.
    Cloney MB; Driscoll CB; Yamaguchi JT; Hopkins B; Dahdaleh NS
    Clin Neurol Neurosurg; 2020 Sep; 196():105982. PubMed ID: 32570019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparin prophylaxis is not associated with decreased incidence of venous thromboembolism in testicular germ cell tumor patients receiving chemotherapy.
    Hapakova N; Chovanec M; Rejlekova K; Kalavska K; Obertova J; Palacka P; De Angelis V; Sycova-Mila Z; Mardiak J; Mego M
    Neoplasma; 2022 Mar; 69(2):456-463. PubMed ID: 35068164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.
    Groot OQ; Ogink PT; Paulino Pereira NR; Ferrone ML; Harris MB; Lozano-Calderon SA; Schoenfeld AJ; Schwab JH
    Clin Orthop Relat Res; 2019 Jul; 477(7):1674-1686. PubMed ID: 31135550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive accuracy of boosted regression model in estimating risk of venous thromboembolism following minimally invasive radical surgery in pharmacological prophylaxis-naïve men with prostate cancer.
    Leong CH; Ranjan SR; Javed A; Alsaedi BSO; Nabi G
    World J Surg Oncol; 2024 Feb; 22(1):67. PubMed ID: 38395873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Ferrante N; Otten HM; Cuccurullo F; Rutjes AW
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008500. PubMed ID: 22336844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty.
    Deng W; Huo L; Yuan Q; Huang D; Li Q; Tian W
    BMC Musculoskelet Disord; 2021 Jul; 22(1):608. PubMed ID: 34229632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended Venous Thromboembolism Chemoprophylaxis following Microsurgical Breast Reconstruction: Analysis of Trends in Postoperative Anticoagulation.
    Le ELH; Saifee J; Constantine R; Tuaño K; Yang J; Kaoutzanis C; Mathes DW; Iorio ML
    Plast Reconstr Surg; 2023 Jul; 152(1):20-27. PubMed ID: 36728476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.
    Vedovati MC; Becattini C; Rondelli F; Boncompagni M; Camporese G; Balzarotti R; Mariani E; Flamini O; Pucciarelli S; Donini A; Agnelli G
    Ann Surg; 2014 Apr; 259(4):665-9. PubMed ID: 24253138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism following colorectal resection.
    El-Dhuwaib Y; Selvasekar C; Corless DJ; Deakin M; Slavin JP
    Colorectal Dis; 2017 Apr; 19(4):385-394. PubMed ID: 27654996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Venous Thromboembolism following Knee Arthroscopy: Effectiveness of a Risk-Based Stratified Chemoprophylaxis Protocol.
    Reynolds AW; Garay M; Lynch S; Black KP; Gallo RA
    J Knee Surg; 2022 Mar; 35(4):443-448. PubMed ID: 32869233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis in the massive weight loss patient: relative risk of bleeding.
    Michaels J; Coon D; Mulvey CL; Rubin JP
    Ann Plast Surg; 2015 Jun; 74(6):699-702. PubMed ID: 24727447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies.
    Matthay ZA; Flanagan CP; Sanders K; Smith EJ; Lancaster EM; Gasper WJ; Kornblith LZ; Hiramoto JS; Conte MS; Iannuzzi JC
    J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):585-593.e2. PubMed ID: 34637952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors associated with venous thromboembolism in 49,028 mastectomy patients.
    Tran BH; Nguyen TJ; Hwang BH; Vidar EN; Davis GB; Chan LS; Woo K; Wong AK
    Breast; 2013 Aug; 22(4):444-8. PubMed ID: 23692931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.